A U.S. federal grand jury indicted Indivior Inc., formerly Reckitt Benckiser Pharmaceuticals Inc., and Indivior plc on one count of health care fraud, four counts of mail fraud and 22 counts of wire fraud related to the company's marketing of Suboxone Film (buprenorphine) as a treatment of opioid addiction.